Keyphrases
General Hospital
83%
Acute Myeloid Leukemia
81%
Clinical Outcomes
74%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
67%
Single-center Retrospective Study
63%
Leukemia Patients
59%
Single Center
54%
Multiple Myeloma
54%
Induction Chemotherapy
50%
Cytarabine
46%
Pulmonary Toxicity
36%
Complete Response
35%
Renal Transplant
35%
Induction Mortality
34%
Clinical Treatment
31%
Anthracyclines
31%
Purine Analogues
31%
All-trans Retinoic Acid
30%
Renal Transplant Recipients
30%
Newly Diagnosed
29%
Current Therapeutics
27%
Treatment Landscape
27%
Renal Cell Carcinoma
27%
Mediastinal Liposarcoma
27%
Stage III Non-small Cell Lung Cancer
27%
Leukaemia Clinical
27%
Blast Crisis
27%
Mixed-phenotype Acute Leukemia
27%
Clinical Diagnosis
27%
Diagnosis Strategy
27%
Therapeutic Strategies
27%
Carfilzomib
27%
Myeloid Leukemia
27%
Cranial Vault Lymphoma
27%
Klebsiella Pneumoniae Bacteremia
27%
Myeloproliferative Neoplasms
27%
Paraneoplastic
27%
Mantle Cell Lymphoma
27%
Bruton Tyrosine Kinase Inhibitor
27%
Acute Leukemia
27%
Leptomeningeal Disease
27%
Tyrosine Kinase Inhibitor Therapy
27%
Axillary Lymphadenopathy
27%
Single Institution
27%
Elderly People
27%
Neck Lymphadenopathy
27%
Unique Pattern
27%
Stiff Person Syndrome
27%
Durable Remission
27%
Warm Autoimmune Hemolytic Anemia
27%
Medicine and Dentistry
Disease
100%
Acute Myeloid Leukemia
81%
Retrospective Study
72%
Acute Myelogenous Leukemia
59%
Multiple Myeloma
58%
Kidney Graft
54%
Acute Leukemia
54%
Induction Chemotherapy
50%
Cytarabine
48%
Bloodstream Infection
44%
Stem Cell Transplant
36%
Pulmonary Toxicity
36%
Radiation Therapy
32%
Purine
31%
Anthracycline
31%
Rituximab
29%
Side Effect
27%
Blast Cell Crisis
27%
Autologous Stem Cell Transplantation
27%
Stiff Person Syndrome
27%
Vasculitis
27%
Pembrolizumab
27%
Evans Syndrome
27%
Axillary Lymphadenopathy
27%
Seminoma
27%
Non Small Cell Lung Cancer
27%
Liposarcoma
27%
Clear Cell Renal Cell Carcinoma
27%
Klebsiella pneumoniae
27%
Primary Sclerosing Cholangitis
27%
Bleomycin
27%
Carfilzomib
27%
Myeloproliferative Neoplasm
27%
Acute Promyelocytic Leukemia
27%
Brain Pseudotumor
27%
Mantle Cell Lymphoma
27%
Glutamate Decarboxylase Antibody
27%
Bruton Tyrosine Kinase Inhibitor
27%
Neck
27%
Myeloid Leukemia
27%
CD135 Antigen
27%
Ecthyma
27%
Pseudomonas aeruginosa
27%
Surgery
26%
Chemotherapy
25%
Biopsy Technique
24%
Prednisone
24%
Central Nervous System
23%
Sepsis
23%
Immune Checkpoint Inhibitor
22%